IMIQUIMOD 5% / TRETINOIN 0.025%- imiquimod 5% / tretinoin 0.025% gel 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

IMIQUIMOD 5% / TRETINOIN 0.025%

Directions for use

wr

Sincerus Florida. Adverse reactions

da

Active, inactive

dw

NDC 72934-1129-2 IMIQUIMOD USP 5% / TRETINOIN USP 0.025%. Gel 30 gm

ca

IMIQUIMOD 5% / TRETINOIN 0.025% 
imiquimod 5% / tretinoin 0.025% gel
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-1129
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TRETINOIN (UNII: 5688UTC01R) (TRETINOIN - UNII:5688UTC01R) TRETINOIN0.025 g  in 100 g
IMIQUIMOD (UNII: P1QW714R7M) (IMIQUIMOD - UNII:P1QW714R7M) IMIQUIMOD5 g  in 100 g
Product Characteristics
ColoryellowScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-1129-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/07/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/07/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Floida, LLC080105003manufacture(72934-1129)

Revised: 5/2019
Document Id: 8839ed49-b52b-11f6-e053-2a95a90a7492
Set id: 8839ed49-b52a-11f6-e053-2a95a90a7492
Version: 1
Effective Time: 20190506
 
Sincerus Florida, LLC